Skokie, IL, United States of America

John W Cusic

This inventor holds 5 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of John W. Cusic

Introduction

John W. Cusic is a notable inventor based in Skokie, IL (US). He has made significant contributions to the field of chemistry, particularly in the development of anti-bacterial and anti-protozoal agents. With a total of 5 patents, his work has had a meaningful impact on medical science.

Latest Patents

Cusic's latest patents include N-[2-(nitro-1-imidazolyl)ethyl]naphthal imides, which describe imides having a nitroimidazolylethyl group as a N-substituent. These compounds are recognized for their anti-bacterial and anti-protozoal properties. The preparation of these compounds involves the reaction of the appropriate imide with chloroethylimidazole or with the tosylate or mesylate of the corresponding hydroxyethyl compound. Another significant patent is for 5-alkyl-10-(aminocarbonyl/aminomethyl/cyano)-10,11-dihydro-5H-dibenz[b,f]azepine-10-alkanamines, which discloses their preparation and highlights their antiarrhythmic and antimicrobial properties.

Career Highlights

John W. Cusic is associated with G.D. Searle & Company, where he has been instrumental in advancing pharmaceutical research. His innovative approaches have led to the development of compounds that address critical health issues.

Collaborations

Cusic has collaborated with notable coworkers such as Charles R. Ellefson and Chi Min Woo. Their combined expertise has contributed to the successful development of various pharmaceutical innovations.

Conclusion

John W. Cusic's contributions to the field of chemistry and pharmaceuticals are commendable. His innovative patents and collaborations reflect his dedication to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…